Medtronic plc (MDT)
MiniMed Group Files For IPO In Medtronic Carve-Out
MiniMed Group, Inc., a Medtronic subsidiary, is targeting an IPO to fund growth and working capital amid diabetes device market expansion. MMED is well-positioned in automated insulin delivery, boasting an integrated product stack, strong recurring revenue, and international reach. Financials show rising revenue and gross profit, but operating leverage remains limited due to high R&D and pending clarity on intercompany debt repayment.
Medtronic: A Defensive Gem For Uncertain Times
Medtronic plc exemplifies a 'wonderful company at a fair price,' trading near its calculated DCF fair value of $98 per share. MDT demonstrates nearly three decades of resilient revenue growth, high margins, and robust shareholder yield, underscoring its defensive investment appeal. The company boasts a 49-year dividend growth streak and has returned 42.2% of market cap to shareholders via buybacks and dividends over the past decade.
Medtronic Spin-Off MiniMed Files for IPO
Medtronic will own at least 80.1% of the voting stock for MiniMed once the IPO is complete.
Why Is Medtronic (MDT) Down 2% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Forget Medtronic, Buy This Healthcare Stock Instead
Medtronic is a solid choice for dividend investors, but Intuitive Surgical is a better option for growth-oriented investors. Intuitive Surgical will continue dominating its niche even as Medtronic enters the market.
Medtronic (MDT) Upgraded to Buy: Here's Why
Medtronic (MDT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MDT or ESLOY: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Medtronic (MDT) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two companies is the best option for those looking for undervalued stocks?
MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System
Medtronic gains from the FDA clearance of its Hugo RAS system, expanding U.S. access to robotic-assisted urologic surgery.
The US Rollout of MiniMed 780G With Abbott's Sensor May Lift MDT Stock
Medtronic begins the U.S. rollout of MiniMed 780G with Abbott's Instinct sensor, advancing diabetes care.
Medtronic Stock Finds Its Footing—Now It's Gaining Momentum
The critical details are that price action cleared a crucial hurdle in early 2025, formed a Golden Crossover, and confirmed a completed market reversal following the fiscal year 2026 (F2026) Q2 earnings release.
S&P 500 Gains and Losses Today: Home Depot Slumps as Earnings Disappoint; Medtronic Stock Jumps
Shares of a major home improvement retailer lost ground after it missed quarterly profit forecasts, indicating homeowners are putting off remodeling projects amid economic uncertainty. Meanwhile, strong demand and procedure volumes helped drive a strong earnings report for a medical device company, and its shares advanced.
Medtronic plc (MDT) Q2 2026 Earnings Call Transcript
Medtronic plc ( MDT ) Q2 2026 Earnings Call November 18, 2025 8:00 AM EST Company Participants Ryan Weispfenning - VP & Head of Investor Relations Geoffrey Martha - Chairman of the Board & CEO Thierry Pieton - Executive VP & CFO Laura Mauri - Senior VP and Chief Scientific & Medical Officer Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Travis Steed - BofA Securities, Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Shagun Singh Chadha - RBC Capital Markets, Research Division Pito Chickering - Deutsche Bank AG, Research Division Presentation Ryan Weispfenning VP & Head of Investor Relations Hello, everyone, and thanks for joining us today for our fiscal '26 second quarter video earnings webcast. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations.
